To include your compound in the COVID-19 Resource Center, submit it here.

BIO still mulling orphan drug compromise

BIO still mulling orphan drug compromise The Biotechnology Industry Organization hopes to discuss its proposed Orphan Drug Act compromise bill at the next executive board meeting at the end of the month, according to spokesperson Eric Christiansen.

According to a draft of the

Read the full 457 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE